207 related articles for article (PubMed ID: 12973869)
1. Thyroid orbitopathy.
Fung S; Malhotra R; Selva D
Aust Fam Physician; 2003 Aug; 32(8):615-20. PubMed ID: 12973869
[TBL] [Abstract][Full Text] [Related]
2. [Endocrine orbitopathy].
Fierz A; Landau K
Praxis (Bern 1994); 2001 May; 90(20):882-6. PubMed ID: 11416973
[TBL] [Abstract][Full Text] [Related]
3. [Thyroid orbitopathy].
Yassur I; Ben Simon GJ; Rosen N
Harefuah; 2003 May; 142(5):377-80, 396. PubMed ID: 12803064
[TBL] [Abstract][Full Text] [Related]
4. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
Juri J; Stiglmayer N; Kuzman T
Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
[TBL] [Abstract][Full Text] [Related]
5. Optimal management of Graves orbitopathy: a multidisciplinary approach.
Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
[TBL] [Abstract][Full Text] [Related]
6. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
[TBL] [Abstract][Full Text] [Related]
7. [Management of Graves' orbitopathy: evidence-based recommendations].
Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
[TBL] [Abstract][Full Text] [Related]
8. [Basedow exophthalmos].
Morax S; Badelon I
J Fr Ophtalmol; 2009 Oct; 32(8):589-99. PubMed ID: 19853965
[TBL] [Abstract][Full Text] [Related]
9. Thyroid-associated ophthalmopathy in Iranian patients.
Kashkouli MB; Jam S; Sabzvari D; Ketabi N; Azarinia S; SeyedAlinaghi S; Mofid A
Acta Med Iran; 2011; 49(9):612-8. PubMed ID: 22052145
[TBL] [Abstract][Full Text] [Related]
10. Graves' ophthalmopathy.
Barrie WE
West J Med; 1993 Jun; 158(6):591-5. PubMed ID: 8337853
[TBL] [Abstract][Full Text] [Related]
11. A treatment strategy for Graves' orbitopathy.
Marcocci C; Pinchera A; Marinò M
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970
[TBL] [Abstract][Full Text] [Related]
12. [Clinical manifestations of thyroid ophthalmopathy].
Fernández Hermida RV; Pinar S; Muruzábal N
An Sist Sanit Navar; 2008; 31 Suppl 3():45-56. PubMed ID: 19169294
[TBL] [Abstract][Full Text] [Related]
13. [The manifestations of 496 cases with thyroid-related immune orbitopathy and normal thyroid function].
Sun F; Song G; Tian W; Zhao H; Pan Y
Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):283-6. PubMed ID: 11877209
[TBL] [Abstract][Full Text] [Related]
14. Thyroid ophthalmopathy.
Levy J; Sobel R; Marcus M; Lifshitz T
Minerva Endocrinol; 2005 Dec; 30(4):247-65. PubMed ID: 16319812
[TBL] [Abstract][Full Text] [Related]
15. No light perception vision from compressive thyroid orbitopathy.
Hornbeak DM; Tamhankar MA; Eckstein LA
Orbit; 2014 Feb; 33(1):72-4. PubMed ID: 24206015
[TBL] [Abstract][Full Text] [Related]
16. Graves' thyroid ophthalmopathy in Ethiopian patients.
Teshome T; Seyoum B
Ethiop Med J; 2001 Jan; 39(1):1-8. PubMed ID: 11338463
[TBL] [Abstract][Full Text] [Related]
17. [Graves' orbitopathy].
Balázs C
Orv Hetil; 2006 Jun; 147(22):1011-7. PubMed ID: 16913090
[TBL] [Abstract][Full Text] [Related]
18. [Graves-Basedow ophthalmopathy in light of current views].
Mirkiewicz-Sieradzka B; Pacura M
Przegl Lek; 2000; 57(6):307-12. PubMed ID: 11107861
[TBL] [Abstract][Full Text] [Related]
19. Clinical assessment of thyroid related orbitopathy: a review.
Vardizer Y; Tomkins O; Briscoe D
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():186-92. PubMed ID: 20467361
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy.
Behrouzi Z; Rabei HM; Azizi F; Daftarian N; Mehrabi Y; Ardeshiri M; Mohammadpour M
J Glaucoma; 2007; 16(4):358-62. PubMed ID: 17570998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
